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Myocardial Depressant Effects of Desflurane
Mechanical and Electrophysiologic Actions In Vitro
Wyun Kon Park, M.D.,* Myung Hee Kim, M.S.,† Duck Sun Ahn, M.D., Ph.D.,‡ Jee Eun Chae, M.S.,§
Young Seok Jee, M.D., Namsik Chung, M.D.,# Carl Lynch III, M.D., Ph.D.**
Background: The authors determined whether desflurane al-
tered myocardial excitation–contraction coupling and electro-
physiologic behavior in the same manner as isoflurane and
sevoflurane.
Methods: The effects of desflurane on isometric force in
guinea pig ventricular papillary muscles were studied in mod-
ified standard and in 26 mM K Tyrode solution with 0.1 M
isoproterenol. Desflurane effects on sarcoplasmic reticulum
Ca2 release were also determined by examining its actions on
rat papillary muscles, guinea pig papillary muscles in low-Na
Tyrode solution, and rapid cooling contractures. Normal and
slow action potentials were recorded using a conventional mi-
croelectrode technique. Ca2 and K currents of guinea pig
ventricular myocytes were examined.
Results: Desflurane (5.3% and 11.6%) decreased peak force to
approximately 70% and 40% of the baseline, respectively, sim-
ilar to the effects of equianesthetic isoflurane concentrations.
With isoproterenol in 26 mM K Tyrode solution, desflurane
markedly depressed late peaking force and modestly depressed
early peak force. The rested state contractions of rat myocar-
dium or guinea pig myocardium in low-Na Tyrode solution
were modestly depressed, whereas rapid cooling contractures
were virtually abolished after desflurane administration. Des-
flurane significantly prolonged the action potential duration.
Desflurane reduced L-type Ca2 current and the delayed out-
ward K current but did not alter the inward rectifier K cur-
rent.
Conclusions: Myocardial depression by desflurane is due to
decreased Ca2 influx, whereas depolarization-activated sarco-
plasmic reticulum Ca2 release is modestly depressed, similar
to the actions of isoflurane and sevoflurane. Desflurane de-
pressed the delayed outward K current associated with signif-
icant lengthening of cardiac action potentials.
DESFLURANE, a structural analog of isoflurane, is a volatile
anesthetic that possesses low blood gas solubility,1 provid-
ing rapid induction and emergence from anesthesia. Dur-
ing maintenance of desflurane anesthesia, a mild decrease
in systemic arterial pressure has been reported clinically.2
Dose-related depression of left ventricular function or car-
diac output by desflurane has been demonstrated in in vivo
animal studies3–6 as well as in humans.7 Direct myocardial
depression by desflurane has been demonstrated in vivo
using dogs subjected to pharmacologic blockade of their
autonomic nervous system,6 and in vitro using guinea pig
(GP) hearts8 and human atria.9 Despite these findings, re-
cent studies using isolated myocardial preparations in rats10
and hamsters11 indicated no significant effect on myocar-
dial contractility. Although a modest effect of desflurane on
sarcoplasmic reticulum (SR) function and indirect evidence
for inhibition of Ca2 entry have been proposed in isolated
myocardial preparations,10,11 the mechanisms underlying
direct myocardial depression has not been well defined.
Therefore, the current study was undertaken to determine
the direct inotropic effects of desflurane and to elucidate
the mechanisms by which desflurane causes contractile
depression using a variety of experimental myocardial mod-
els, inotropic interventions, and electrophysiologic meth-




Experiments with Modified Standard Tyrode So-
lution. According to a procedure approved by the Yonsei
University College of Medicine Animal Research Commit-
tee (Seoul, Korea), the heart was removed from 400- to
450-g female GPs or rats (Sprague-Dawley) after halothane
anesthesia (2.5–4 vol%). Next, the right ventricular papil-
lary muscles were excised, mounted horizontally in a tissue
bath, and superfused (8 ml/min) at 37°C with modified
standard Tyrode solution (118 mM NaCl, 5 mM KCl, 2 mM
CaCl2, 1.2 mM MgSO4, 25 mM NaHCO 3
, 11 mM glucose,
0.10 mM EDTA). EDTA was used to chelate any trace con-
taminant heavy metals. The solution was circulated
through a bath from an unsealed reservoirs through which
a mixture of 95% O2 and 5% CO2 was bubbled (flow rate:
0.5 l/min) to maintain a pH of 7.4  0.05. The tendinous
end of the papillary muscle was attached to a Grass FT03
force transducer (Grass Instruments, Quincy, MA) while
the other end of the muscle was pinned to the bottom of
the tissue bath. The length of the muscle was adjusted
to the lowest resting force at which maximum twitch force
was obtained. The muscles were field-stimulated using a
Grass S44 stimulator (Grass Instruments) at 120% of stimu-
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lus threshold at 0.5 Hz for 60 min for stabilization. After a
15-min rest, a rested state (RS) contraction was elicited,
followed by stimulation rates of 0.1, 0.5, 1, 2, and 3 Hz,
sequentially. At each stimulation rate, the duration of stim-
ulation was preset and kept constant during the experi-
ment. After baseline measurements, the muscles were suc-
cessively exposed to 6% and 12% desflurane (vaporizer
setting) or 1.15% and 2.3% isoflurane (vaporizer setting),
each for 15 min, at which the response were recorded. In
pilot experiments, a 15-min application of desflurane was
sufficient to produce a stable and consistent effect. Recov-
ery responses were measured after a 20-min washout pe-
riod. Effects on contractile function were estimated from
the peak force (PF) and maximum rate of force develop-
ment (dF/dt-max).
Effects of Desflurane on Catecholamine-mediated
Responses. To examine the effects of desflurane on
catecholamine release from the ventricular myocardi-
um,10 both receptor blockade and catecholamine deple-
tion were used. In an initial control study, a positive
inotropic response to tyramine (30 M) was used to
verify that the GP ventricular myocardium has catechol-
amine-containing sympathetic nerve endings.
In the first experimental series, muscles were exposed
to phentolamine (1 M) and propranolol (1 M) to pre-
vent catecholamine activation of  and  adrenoceptors
on the cardiac membrane. After a 15-min pretreatment
and measurement of baseline contractile forces, contrac-
tions were recorded after a 15-min application of desflu-
rane. Recovery was observed after a 20-min washout
period (phentolamine and propranolol were maintained
throughout). In a separate experimental group, a lack of
response to a 15-min application of tyramine (30 M)
was used to verify that the blockade of adrenoceptors by
phentolamine and propranolol was adequate.
In the second experimental series, the ventricular myo-
cardium was depleted of catecholamines by an intraperito-
neal injection of reserpine (4 mg/kg) into the GPs 24 h
before the experiment.16 The depletion of catecholamine
was verified by the absence of a positive inotropic response
to an occasional threefold increase of stimulus voltage dur-
ing the 60-min stabilization period, because high stimulus
intensity can activate catecholamine release from sympa-
thetic nerve endings. Contractile measurements were
taken during control conditions, after a 15-min application
of 6% desflurane, and after a 20-min washout. In a separate
experimental group, the depletion of catecholamine by
reserpine was also verified by a lack of contractile enhance-
ment after treatment with tyramine.
Evaluation of Sarcoplasmic Reticulum Function In
Situ
Rat Papillary Muscle. Rat papillary muscles were
used to evaluate the effects of desflurane on contractions
caused almost exclusively by Ca2 release from the SR.
After baseline measurements at RS, the muscles were
exposed to 12% desflurane for 15 min. Recovery re-
sponses were measured after a 20-min washout.
Experiments with Low-Na (25 mM) Tyrode Solu-
tion. Experiments using GP papillary muscles in low-
Na (25 mM) Tyrode solution (25 mM NaHCO 3
, 5 mM
KCl, 2 mM CaCl2, 1.2 mM MgSO4, 11 mM glucose, 0.1 mM
EDTA, 234 mM sucrose) were performed to confirm the
effect of desflurane in rat force studies and to rule out
the species-dependent differences in SR Ca2 release.
After obtaining baseline measurements at RS after a 15-
min rest, muscles were exposed to 12% desflurane for 15
min. Recovery responses were measured after a 20-min
washout.
Rapid Cooling Contracture. When isolated strips of
myocardium are rapidly cooled, a contracture develops
as a result of sudden release of Ca2 from the SR,17 used
as an index of the SR Ca2 content. Using GP papillary
muscles, stimulation was gradually increased from 0.1 to
2 Hz until a stable contraction was obtained. The dura-
tion of stimulation at each stimulation rate was preset
and kept constant during the experiment. Immediately
after the abrupt cessation of the stimulus, a rapid cooling
contracture (RCC) was triggered by rapidly changing the
perfusion of modified standard Tyrode solution (flow
rate: approximately 50 ml/min) from 37°C to 0°C, which
decreased the temperature to less than 5°C within 2–4 s.
Cooling was maintained for 60 s, after which perfusion
with 37°C modified standard Tyrode solution was re-
sumed. After determination of the control response, the
identical protocol was repeated after a 15-min exposure
to 6% desflurane, a 15-min exposure to 12% desflurane,
and lastly after a 20-min washout. Isometric force and
bath temperature were continuously recorded during
the experiment.
Experiments with Isoproterenol Stimulation (in
26 mM K Tyrode Solution). -Adrenergic stimulation
with 0.1 M isoproterenol enhances contractility by in-
creasing Ca2 entry via L-type Ca2 (ICa,L) channels
18,19
as well as an increasing Ca2 uptake into and release
from the SR.20 When applied in 26 mM K Tyrode solu-
tion (97 mM NaCl, 26 mM KCl, 2 mM CaCl2, 1.2 mM
MgSO4, 25 mM NaHCO 3
, 11 mM glucose, 0.1 mM EDTA),
there is partial depolarization of the myocardium to 40
to 45 mV, which inactivates fast Na channels, while
permitting conduction of slow action potentials (APs)
(mediated by ICa,L). After recording the biphasic contrac-
tions12,13,15,21 under control conditions at RS up to 3-Hz
stimulation rate, contractions at the same stimulation
rates were recorded after application of 6% and 12%
desflurane (applied sequentially for 15 min each). Recov-
ery responses were measured after a 20-min washout.
After each force experiment, muscle cross-sectional
area was estimated from muscle length, weight, and
density (1.04 g/ml), assuming a cylindrical form. Mean
cross-sectional areas were 0.82  0.37 mm2 (n  65,
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from 0.24 to 1.99 mm2) and 0.81  0.26 mm2 (n  5,
from 0.54 to 1.15 mm2) in GPs and rats, respectively.
Electrophysiologic Studies
Papillary Muscle APs. Papillary muscle membrane
potential was monitored with conventional 3 M KCl–
filled glass microelectrodes (10–20 M) attached to a
VF-1 preamplifier (World Precision Instruments, Sara-
sota, FL). Membrane potential and its maximum rate of
rise during the AP (dV/dt-max) were monitored on a
digital storage oscilloscope. Because the vigorous con-
tractions at higher stimulation rates (2 and 3 Hz) often
caused dislodgement of impaled microelectrodes, only
results from an impalement maintained throughout the
whole sequence at 0.25-Hz stimulation rate were tabu-
lated. Stimulation intensity was maintained at approxi-
mately 120% of the lowest intensity necessary to elicit a
response and then adjusted to maintain approximately
the same latency (stimulus–action potential interval, usu-
ally 5–10 ms). AP amplitude, dV/dt-max, and AP duration
at 50% and 90% of repolarization (APD50 and APD90,
respectively) were measured at 0.25-Hz stimulation rate
in modified standard Tyrode solution and in 26 mM K
Tyrode solution with 0.1 M isoproterenol.
Isolated Myocyte Studies.
Isolation of Ventricular Myocytes. Guinea pigs (ap-
proximately 300 g) were anesthetized with halothane at
2.5–4 vol%. The heart was quickly excised and retro-
gradely perfused using a Langendorff perfusion system.
The heart was perfused for 5 min at 37°C at a rate of 7
ml/min with modified Tyrode solution (143 mM NaCl,
5.4 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 5 mM HEPES,
0.18 mM glucose, pH 7.4). The perfusate was then
switched for 5 min to a nominally Ca2-free Tyrode
solution followed by perfusion with the same solution to
which collagenase (0.4 mg/ml, Worthington type II;
Worthington Biochemical Corporation, Lakewood, NJ)
and protease XIV (0.04 mg/ml; Sigma-Aldrich Co., St.
Louis, MO) had been added. After a 10- to 12-min enzy-
matic treatment, Kraftbru¨he solution (10 mM taurine, 10
mM oxalic acid, 70 mM glutamic acid, 35 mM KCl, 10 mM
H2PO4, 11 mM glucose, 0.5 mM EGTA, 10 mM HEPES, pH
7.4) was perfused for 5 min. The ventricles were then
cut off and minced with scissors and agitated in a small
beaker with Kraftbru¨he solution, and the resulting slurry
was filtered through a 200-m nylon mesh. The isolated
ventricular cells were stored in Kraftbru¨he solution for
1 h at room temperature (21°–22°C), kept at 4°C, and
used within 8 h. Only the rod-shaped cells with apparent
striations that remained quiescent in the solution con-
taining 2 mM CaCl2 were used for the experiments. All
patch clamp experiments were conducted at room tem-
perature.
Electrophysiologic Techniques. Isolated myocytes
were allowed to settle to the bottom of a recording
chamber mounted on an inverted microscope where the
bathing solutions could be exchanged. The chamber was
continuously perfused at a rate of 2 ml/min. Standard
whole cell voltage clamp methods were used.22 After the
initiation of the whole cell recording configuration, an
interval of 4–6 min was allowed to establish a stable
baseline. Voltage clamp measurements were performed
using an Axopatch 200B patch clamp amplifier (Axon
Instruments, Foster City, CA). Patch electrodes were
prepared from a borosilicate glass model KIMAX-51
(American Scientific, Charlotte, NC), which have a typi-
cally 2–3 M resistance when filled with an internal
solution. After fabrication with a two-stage micropipette
puller, the pipette tips were heat-polished with a micro-
forge. Data acquisition was performed using a pCLAMP
system version 6.0 (Axon Instruments) coupled with a
Pentium III personal computer.
Voltage Clamp Protocols. Simultaneous recordings of
delayed outward K current (IK) and inward rectifier K

current (IKI) were obtained using a linear voltage ramp
protocol in which the cells were held at 40 mV before
sweeping the membrane potentials from 130 to 50
mV at a rate of 30 mV/s. For the detailed evaluation of
desflurane effect on IK, the IK was measured by step
depolarizations from 30 to 80mV with a holding
potential of 40 mV in 20-mV increments, 5-s intervals,
and 4-s pulse duration. The voltage-dependent ICa,L was
evoked by step depolarization lasting 200 ms from a
holding potential of 40 to 10 mV in one step at a
frequency of 0.1 Hz.
Solutions. An external bathing solution (140 mM NaCl,
5.4 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, 10
mM glucose, adjusted to pH 7.4 with 1N NaOH) was used
before establishing the whole cell recording. For K
current measurements, a patch pipette solution (20 mM
KCl, 110 mM K-aspartate, 10 mM EGTA, 10 mM HEPES, 1
mM MgCl2, 5 mM K2ATP, 1 mM CaCl2, 10 mM NaCl,
adjusted to pH 7.2 with KOH) was used before estab-
lishing the whole cell recording configuration. After es-
tablishing the whole cell voltage clamp, 0.2 mM CdCl2
was added to the external bathing solution to eliminate
any confounding Ca2 current. Inward Ca2 currents
were measured using a patch pipette solution (30 mM
CsCl, 100 mM aspartic acid, 100 mM CsOH, 10 mM
BAPTA, 10 mM HEPES, 10 mM phosphocreatinine, 1 mM
Na2GTP, 5 mM Na2ATP, 10 mM glucose, 2 mM MgCl2,
adjusted to pH 7.25 with 1 M CsOH). Upon obtaining the
whole cell recording, the external bathing solution was
exchanged to a solution (140 mM NaCl, 5.4 mM CsCl, 2
mM CaCl2, 1 mM MgCl2, 10 mM HEPES, adjusted to pH 7.4
with 1 M CsOH) to measure ICa,L.
After the baseline measurement, the myocytes were
exposed to 6% or 12% desflurane for 2 min. Recovery
responses were measured after a 2-min washout. In pilot
experiments, a 2-min application of desflurane was suf-
ficient to produce a stable and consistent effect.
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Drugs and Chemicals
In contraction and AP experiments at 37°C, desflurane
or isoflurane was equilibrated with solution in one res-
ervoir by passing the 95% O2–5% CO2 gas mixture (flow
rate: 0.5 l/min) through a desflurane (Devapor Type
M32600; Dra¨ger AG, Lu¨beck, Germany) or isoflurane
(Isotec 3; Ohmeda, West Yorkshire, United Kingdom)
vaporizer for 15 min. The end-tidal concentrations of
desflurane or isoflurane were monitored with a gas ana-
lyzer (Capnomac; Datex, Helsinki, Finland) that had
been calibrated before use. Isoflurane was used to com-
pare contractile parameters with approximately equi-
anesthetic concentrations of desflurane.
As determined by gas chromatographic measurement,
desflurane concentrations in the 37°C Tyrode superfu-
sate that had been equilibrated for 15 min were 0.42 
0.06 mM (n  3) and 0.91  0.05 mM (n  4) for 6% and
12% desflurane, respectively. Considering that the Ty-
rode solution/gas partition coefficient is 0.2 at 37°C,23
desflurane at 0.42 mM and 0.91 mM correspond to gas
phase concentrations of 5.3% (0.89 minimum alveolar
concentration [MAC]) and 11.6% (1.93 MAC), respec-
tively. As previously reported, the equilibrated concen-
trations of isoflurane at 37°C were 0.22 mM for 1.3% and
0.42 mM for 2.5%,14 corresponding to 1.0% (0.77 MAC)
and 1.9% (1.45 MAC) gas phase isoflurane at 37°C, re-
spectively, based on a Tyrode solution/gas partition co-
efficient of 0.57 at 37°C.23
During myocyte experiments at room temperature,
desflurane was equilibrated with an external bathing
solution in one reservoir by passing 100% O2 (flow rate:
0.2 l/min) through the desflurane vaporizer for 15 min.
Concentrations of 0.78  0.05 mM (n  3) and 1.23 
0.03 mM (n  3) were measured for 6% and 12% desflu-
rane, respectively. Given that the Tyrode solution/gas
partition coefficient is 0.27 at 22°C,23 the aforemen-
tioned desflurane concentrations were equivalent to gas
phase concentrations of 7.0% and 11.0%, respectively.
An aqueous concentration of 0.78 mM desflurane at 22°C
is equivalent to approximately 9.9% desflurane gas phase
at 37°C.
Tyramine, phentolamine, propranolol, and reserpine
were purchased from the Sigma-Aldrich Chemical Com-
pany (St. Louis, MO). To obtain a 1-mg/ml solution of
reserpine, reserpine (20 mg) was dissolved in 0.5 ml
glacial acetic acid and 1 ml propylene glycol, and then
brought to a volume of 20 ml with distilled water. The
pH was adjusted to 4.98 with 10N NaOH. Unless other-
wise stated, all chemicals were purchased from the Sig-
ma-Aldrich Chemical Company.
Statistical Analysis
Because of the variations in baseline values from one
muscle to another, alterations in contractile responses
were expressed as a percentage of baseline. In papillary
muscle and isolated myocyte experiments, repeated-
measures analysis of variance followed by Student-New-
man-Keuls test was applied to test for statistically signif-
icant differences among the baseline, drug application,
and washout period as well as among the stimulation
rates. An unpaired t test was used to compare the con-
tractile forces between the equianesthetic concentra-
tions of desflurane and isoflurane, and to compare the
differences between 6% and 12% concentrations of des-
flurane. To compare the effects of desflurane among
control conditions, groups with adrenoceptor blockade,
and reserpine-treated groups, one-way analysis of vari-
ance followed by Student-Newman-Keuls test was ap-
plied. All results were expressed as mean  SD. A P
value less than 0.05 was considered significant.
Results
Effects on Contractility
Experiments with Modified Standard Tyrode So-
lution. Desflurane caused concentration-dependent de-
pression of PF to approximately 70% and 40% of baseline
from RS to 3-Hz stimulation rates, respectively (n  7,
P  0.05; fig. 1A). Equianesthetic concentrations of
isoflurane depressed contractions to approximately 75%
and 50% of baseline, respectively (n  5, P  0.05; fig.
1B). At each stimulation rate, the contractile depression
caused by equianesthetic concentrations of desflurane
and isoflurane were not different (not significant [NS]).
The effects of desflurane and isoflurane on contractile
forces did not seem to depend on the stimulation fre-
quencies. Whereas the contractile force recovered to
50–60% of baseline after a 20-min washout of desflu-
rane, equianesthetic concentration of isoflurane exhib-
Fig. 1. Effects of equianesthetic concentrations of desflurane
(n  7; A) and isoflurane (n  5; B) on myocardial peak force at
the indicated stimulation rates in guinea pig papillary muscles.
The muscles were successively exposed to 5.3% and 11.6% des-
flurane or 1.0% and 1.9% isoflurane. Dotted lines indicate the
20-min washout after application of 11.6% desflurane or 1.9%
isoflurane. Error bars indicate SD. * Differences from control
(P < 0.05). † Differences from 5.3% desflurane or 1.0% isoflu-
rane, respectively (P < 0.05). RS  rested state.
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ited complete recovery. There was no further recovery
after an additional 20-min washout of desflurane (data
not shown). The baseline values of PF are shown in table
1.
Tyramine increased the contractile forces to approxi-
mately 200% of the baseline from RS to 3-Hz stimulation
rates (RS: 179  43%, 0.1 Hz: 168  39%, 0.5 Hz: 186 
36%, 1 Hz: 217  70%, 2 Hz: 210  61%, 3 Hz: 162 
23%, n  6). The contractile forces returned to baseline
values after washout for 20 min. Treatment with tyra-
mine (30 M) after - and -adrenoceptor blockade (n 
6) or in reserpinized myocardium (n  6) did not alter
the contractile force at each stimulation rate (fig. 2A).
Whereas application of - and -adrenoceptor blockers
did not alter the contractile force at RS and 0.1-Hz stim-
ulation rates, a modest but statistically significant depres-
sion to approximately 85% of baseline was observed at 1-
to 3-Hz stimulation rates (fig. 2B). Application of desflu-
rane (5.3%) after - and -adrenoceptor blockade de-
pressed the contractile force to approximately 50% and
40% of baseline at RS to 1 Hz and higher stimulation
rates, respectively (n 6, P 0.05; fig. 2B). After - and
-adrenoceptor blockade (n  8) or in reserpinized
myocardium (n  8), the contractile depression by 5.3%
desflurane did not differ from the effects observed under
control conditions (fig. 3). To eliminate the contribution
of contractile depression by - and -adrenoceptor
blockade, fractional depression by desflurane was com-
pared with - and -blockade baseline values. The base-
line values of PF among these three groups are shown in
table 2. Similar to the muscles in the absence of phar-
macologic sympathetic blockade, partial recovery was
observed in the three aforementioned groups at all stim-
ulation rates (data not shown).
Evaluation of Sarcoplasmic Reticulum Function In
Situ
Rat Papillary Muscle. Unlike GP muscle, rat muscle
SR does not become depleted of Ca2 during rest, but
rather accumulates it due to its higher resting intracellu-
lar [Na],24,25 resulting in a large RS contraction. Rat
papillary muscles also exhibit a negative force–fre-
quency relation, which may be related to hypoxia.26
Because of the potential for hypoxic alteration, particu-
larly at high stimulation rates, the effect of desflurane
(11.6%) was only examined at RS. Alteration of the RS
contractile force was not observed in either the pres-
ence of desflurane (7.65  2.09 vs. 6.99  1.91 mN/
mm2, n  5, NS) or after a 20-min washout (7.65  2.09
vs. 7.19  1.91 mN/mm2, n  5, NS).
Experiments with Low-Na (25 MM) Tyrode Solu-
tion. In GP myocardium, Ca2 extrusion via the Na–
Ca2 exchange is markedly reduced by low extracellular
Na concentration so that Ca2 is accumulated in SR
during rest,19,25 leading to an enhanced RS contraction
similar to the behavior of rat myocardium. Contractions
in low-Na Tyrode solution require a modest Ca2 cur-
rent as evidenced by the fact that these contractions are
hardly inhibited by nifedipine.19 Desflurane (11.6%) did
not alter the RS contraction (7.34  2.33 vs. 6.96  2.03
mN/mm2, n  6, NS).
Rapid Cooling Contracture. After a 2-Hz stimulation
rate, desflurane (5.3%) markedly depressed the RCC
(13  7% of baseline, 3.60  0.52 vs. 0.46  0.10
Table 1. Baseline Values of Peak Force in Modified Standard Tyrode Solution
RS 0.1 Hz 0.5 Hz 1 Hz 2 Hz 3 Hz
Desflurane (n  7) 0.25 (0.17) 0.52 (0.35) 0.46 (0.28) 0.62 (0.39) 2.23 (1.66) 3.96 (3.01)
Isoflurane (n  5) 0.28 (0.20) 0.47 (0.37) 0.39 (0.31) 0.7 (0.54) 2.19 (1.67) 3.92 (3.01)
Results are presented as mean (SD). Peak force (mN/mm2).
RS  rested state.
Fig. 2. (A) Effects of tyramine (30 M) on in-
tramyocardial catecholamine release at 1-Hz
stimulation rate in guinea pig papillary mus-
cles. In muscles subjected to - and -adreno-
ceptor blockade with phentolamine (1 M)
and propranolol (1 M) or reserpine, tyra-
mine did not alter the contractile force (n 
6). * Differences from the muscles subjected
to - and -adrenoceptor blockade or reser-
pine (P< 0.05). (B) Effect of 5.3% desflurane–
treated muscles subjected to - and -adreno-
ceptor blockade with phentolamine (1 M)
and propranolol (1 M). Dotted lines indicate
washout for 20 min. Results are presented as
mean  SD. n  6/group. * P < 0.05 versus
the baseline. † Differences from the muscles
subjected to - and -adrenoceptor blockade
(P < 0.05). RS  rested state.
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mN/mm2, n  7, P  0.05), and similar depression was
shown with 11.6% desflurane (11 7% of baseline, 3.60
0.52 vs. 0.36 0.07 mN/mm2, n 7, P 0.05). The time
to peak contractures could not be determined because
the shape of the RCC was almost abolished so that no
peak was definable (fig. 4). There was incomplete recov-
ery of the RCC amplitude after a 20-min washout of 5.3%
desflurane (28 12% of baseline, 3.60 0.52 vs. 0.97
0.18 mN/mm2, P  0.05; fig. 4).
Experiments with Isoproterenol Stimulation (in
26 mM K Tyrode Solution). With -adrenergic stim-
ulation in 26 mM K Tyrode solution, the pattern of force
after rest and up to 0.5- to 1-Hz stimulation rate consis-
tently demonstrated a distinct early and late phase of
force development, defined as dFE/dt-max and dFL/dt-
max, respectively.12,13,15,21 Whereas the early peak of
the biphasic contraction elicited is activated by Ca2
accumulated during previous depolarizations and re-
leased immediately upon rapid depolarization of the
membrane, the late peaking force is attributed to the
Ca2 that enters the cell during the initial phase of the
AP, is taken up into the SR, and is subsequently released
late in depolarization.15,19,21 This late peaking force is
depressed by L-type Ca2 channel blockers such as ni-
fedipine.15,19,21 In contrast, ryanodine decreases the ini-
tial force development15,21 by putting the cardiac Ca2
release channel (RyR2) in a low conductance state and
decreasing the SR Ca2 available for immediate release,
although the late release is not inhibited.15 The baseline
values of PF, dFE/dt-max, and dFL/dt-max are shown in
table 3. Desflurane at 5.3% and 11.6% resulted in a
marked depression of late force development (5.3%:
approximately 40% of baseline, 11.6%: approximately
20% of baseline, n  7) with a modest to moderate
depression of early force development (5.3%: approxi-
mately 80% of baseline, 11.6%: approximately 60% of
baseline) (figs. 5A–C). After a 20-min washout, near-
complete (P  0.05) and complete (NS) recovery of
dFE/dt-max and dFL/dt-max, respectively, were present.
Electrophysiologic Studies
Papillary Muscle APs. In normal APs, desflurane
(11.6%) altered neither the amplitude nor the dV/dt-max
at 0.25-Hz stimulation rate, although the APD50 and
Fig. 3. Effects of 5.3% desflurane on contractile forces in con-
trol conditions (n  7), after - and -adrenoceptor blockade
with phentolamine (1 M) and propranolol (1 M) (n  8), or
after pretreatment of reserpine (n 8) in guinea pig ventricular
myocardium. Results are presented as mean  SD. RS  rested
state.
Table 2. Baseline Values of Peak Force in the Groups Treated with Desflurane, and Pretreated with  and  Blockers or Reserpine
Followed by Desflurane in Modified Standard Tyrode Solution
RS 0.1 Hz 0.5 Hz 1 Hz 2 Hz 3 Hz
Desflurane (n  7) 0.25 (0.17) 0.52 (0.35) 0.46 (0.28) 0.62 (0.39) 2.23 (1.66) 3.96 (3.01)
,  Blockers (n  8) 0.24 (0.15) 0.42 (0.24) 0.43 (0.23) 0.49 (0.24) 1.21 (0.46) 2.22 (0.78)
Reserpine (n  7) 0.55 (0.13) 1.06 (0.27) 0.99 (0.30) 0.99 (0.35) 2.66 (0.71) 4.89 (0.66)
Results are presented as mean (SD). Peak force (mN/mm2). There were no significant differences between the groups treated with desflurane and  and 
blockers followed by desflurane. The group pretreated with reserpine was not compared with the other two groups because the baseline conditions were
different.
RS  rested state.
Fig. 4. A typical record of 5.3% desflurane on the rapid cooling
contractures in guinea pig myocardium. Steady state contractile
force evoked by 2-Hz stimulation rate (shown at high and low
chart speed) followed by immediate cooling from 37°C to less
than 3°C achieved within 1.5 s, as shown by the temperature
measurement in bottom record. Note that while desflurane-
induced depression in the electrically evoked contractions
showed partial recovery, the effect of desflurane on the rapid
cooling contracture was not recovered to baseline value at all.
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APD90 were prolonged significantly (APD50: 113 7% of
baseline, APD90: 111  6% of baseline, n  6; table 4).
No changes in resting membrane potential, which
ranged from 87 to 92 mV, were observed. In slow
APs, whereas desflurane (11.6%) altered neither the AP
amplitude nor the dV/dt-max at 0.25-Hz stimulation rate,
the APD50 and APD90 were also prolonged (APD50: 109
 29% of baseline, APD90: 115 15% of baseline, n 6;
table 4). No changes in resting membrane potential,
which ranged from 39 to 44 mV, were observed.
Isolated Myocyte Studies.
Inward Rectifier K Current. Using a linear voltage
ramp protocol, peak inward IKI at 130 mV was not sig-
nificantly reduced by 0.78 mM (n  13) or 1.23 mM desflu-
rane (n 13) from the control values of4.74 1.08 and
4.35  1.32 nA, respectively. The peak outward compo-
nent of IKI elicited at potentials ranging from 60 or 50
mV was also unchanged by 0.78 mM (n  13) or 1.23 mM
desflurane (n 13) from the control values of 0.29 0.13
and 0.34  0.19 nA, respectively. A typically observed
response is shown in figures 6A and B.
Delayed Outward K Current. Whereas IKI did not
seem to be significantly reduced by desflurane, the cur-
rent–voltage relation presented in figure 6 indicates that
the outward K current recorded at membrane poten-
tials positive to 20 mV, which primarily represents IK,
was depressed by desflurane. The peak outward IK as-
sessed at60 mV was reduced significantly to 63 19%
(n  13, P  0.05) and 58  12% (n  13, P  0.05) of
the baseline values by 0.78 mM and 1.23 mM desflurane
from its baseline values of 0.37  0.27 nA and 0.37 
0.27 nA, respectively (fig. 6C). Complete recovery was
observed after washout (fig. 6A). A more detailed study
of time-dependent IK was performed by measuring the
amplitude of IK at the end of a step depolarization to 80
mV. Desflurane (0.78 mM) reduced the IK to 57 22% (n
5, P  0.05) from its baseline value of 1.08  0.31 nA,
whereas 1.23 mM desflurane reduced IK to 61  13% (n 
7, P  0.05) from its baseline value of 0.71  0.12 nA
(figs. 7A–D). Washout of desflurane resulted in a com-
plete recovery.
L-type Ca2 Current. At a membrane potential of 10
mV, peak ICa,L was reduced to 58  6% of baseline (n 
5, P  0.05) by 1.23 mM desflurane from its baseline
value of 0.45  0.09 nA (figs. 8A and B). Desflurane
(0.78 mM) reduced peak ICa,L to 77  6% (n  5, P 
0.05) of baseline from its baseline value of 0.4  0.07
nA (fig. 8B). Complete recovery was shown after wash-
out (fig. 8A).
Discussion
The results of the current study demonstrate that desflu-
rane depresses the contractile force in a concentration-
dependent manner, similar to the effect of equianesthetic
concentration of isoflurane. Myocardial depression by
desflurane has been well characterized in isolated atrial9
and ventricular tissues,8,10,11 in intact animal studies,3–6
and in clinical settings.2,7 Whereas most in vivo ani-
mal3,5,6 and human studies2 have reported similar degree
of contractile depression with equianesthetic concentra-
tion of desflurane and isoflurane, other in vivo animal
studies have demonstrated conflicting results showing
Table 3. Baseline Values of Main Mechanical Parameters in 26 mM K Tyrode Solution with 0.1 M Isoproterenol
RS 0.1 Hz 0.25 Hz 0.5 Hz 1 Hz 2 Hz 3 Hz
PF 3.85 (4.96) 3.80 (4.97) 4.0 (5.49) 4.05 (5.47) 3.62 (5.04) 3.99 (5.30) 3.82 (4.71)
dFE/dt-max 11.04 (12.17) 13.12 (16.84) 13.27 (15.26) 15.82 (19.26) 29.25 (39.22) 57.43 (68.01) 65.10 (80.72)
dFL/dt-max 35.74 (46.83) 35.49 (46.88) 37.10 (51.18) 37.10 (51.17) 32.35 (40.49)
Results are mean (SD) (n  7).
dFE/dt-maxmaximum rate of early force development (mN · s
1· mm2); dFL/dt-maxmaximum rate of late force development (mN · s
1· mm2); PF peak
force (mN/mm2); RS  rested state.
Fig. 5. Effects of desflurane on myocar-
dial force development in 26 mM K Ty-
rode solution with 0.1 M isoproterenol
in guinea pig ventricular myocardium.
(A) Effects of 5.3% and 11.6% desflurane
on average peak force. Effects of 5.3%
and 11.6% desflurane on maximum rate
of early, dFE/dt-max (B), and late force
development, dFL/dt-max (C), as a func-
tion of stimulation rate (n  7). Muscles
were successively exposed to 5.3% and
11.6% desflurane. Dotted lines indicate
washout for 20 min after application of
11.6% desflurane. Error bars indicate
SD. * Differences from control (P < 0.05).
† Differences from 5.3% desflurane (P <
0.05). RS  rested state.
962 PARK ET AL.
Anesthesiology, V 106, No 5, May 2007
greater27 or less4 depression than isoflurane. Using a GP
heart Langendorff preparation, Bovan et al.8 demon-
strated that desflurane caused a slightly greater depres-
sion of isovolumic left ventricular pressure than did an
equianesthetic concentration of isoflurane, although
greater contractile depression by isoflurane has been
reported in rat10 and hamster myocardium11 as well as
human atrial tissue.9 The contractile depression ob-
served in this study is compatible with the report by
Bovan et al.8 (approximately 40% of control with 11.7%
desflurane), and slightly greater than the depression doc-
umented by Pagel et al.6 (approximately 75% of baseline
by 1 MAC desflurane) in chronically instrumented dogs
with pharmacologic blockade of the autonomic nervous
system.
A curious observation was the incomplete recovery of
normal contractions that we observed after the 20-min
washout of desflurane. In previous studies examining
isoflurane12 or sevoflurane,13 a complete recovery of
contractions was observed after a 20-min anesthetic
washout. In the current study, identical experiments
using isoflurane showed a complete reversal of contrac-
tile depression, indicating that there is no time-depen-
dent deterioration in our experimental preparation. To
verify the incomplete recovery, we examined four more
muscles (control, 11.6% desflurane, and washout) and
reconfirmed similar depression (approximately 40%) and
recovery (approximately 60%) from RS to 3-Hz stimula-
tion rates. In previous work performed in the same
superfused preparation, the depressant effects of propo-
Table 4. Effects of Desflurane (11.6%) in Normal and Slow









Normal APs (n  6)
Control 128  14 173  16 206  17 126  32
Desflurane 130  15 195  13* 228  15* 123  30
Recovery 131  14 191  6 220  8 132  32
Slow APs (n  6)
Control 102  3 165  29 190  32 16  4
Desflurane 104  3 174  31* 215  23* 16  4
Recovery 104  4 175  22 201  28 16  3
Results are presented as mean  SD. Repeated-measures analysis of vari-
ance followed by Student-Newman-Keuls test was used to test for differ-
ences among groups.
* P  0.05 vs. control.
AP action potential; APD50 and APD90 the duration of the AP at 50% and
90% of repolarization, respectively; dV/dt-max  maximum rate of depolar-
ization of the AP.
Fig. 6. (A) Effects of desflurane on the inward rectifier (IKI) and
delayed outward K currents (IK) in a guinea pig ventricular
myocyte. Currents were recorded in response to a linear voltage
ramp protocol in which the cells were held at 40 mV before
their membrane potential was swept from 130 to 60 mV at a
rate of 30 mV/s. A dotted line indicates recovery. (B) Effects of
desflurane on outward component of IKI. (C) Effects of 0.78 mM
and 1.23 mM desflurane on IK in guinea pig ventricular myo-
cytes. * P < 0.05 versus control. Error bars indicate SD.
Fig. 7. (A and B) Effects of desflurane on delayed outward K
currents (IK) in a guinea pig ventricular myocyte. IK was mea-
sured by step depolarizations from 30 to 80 mV from a
holding potential of 40 mV in 20-mV increments with 5-s
intervals. Dotted lines indicate zero current. (C) The corre-
sponding current–voltage relations of IK. * P < 0.05 versus
control. (D) Effects of 0.78 mM and 1.23 mM desflurane on IK.
* P < 0.05 versus control. Error bars indicate SD.
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fol were only partially reversible with washout.28 Like
propofol, desflurane is highly hydrophobic and, once
absorbed by the tissue, will diffuse from the tissue and
dissolve in the aqueous medium very slowly. In isopro-
terenol-stimulated muscles in 26 mM K Tyrode solution
in the current study, the effects of desflurane seemed to
be more reversible on washout. The much more vigor-
ous contractions would increase solution contact and
diffusion from the tissue, whereas with weak contrac-
tions and minimal motion, diffusion into solution would
be restricted by unstirred layers of solution inside and
outside the tissue.
In heart muscles, the depolarization-activated release
of SR Ca2 is mediated by Ca2 entering the myocyte
and triggering the opening of the SR Ca2 release chan-
nels (type 2 ryanodine receptors, RyR2), a process
termed Ca2-induced Ca2 release (CICR). Over re-
peated cardiac cycles, depression of ICa,L will also result
in a decrease of Ca2 accumulation in the SR available
for subsequent release, consistent with the contractile
depression of normal contractions observed with L-type
Ca2 channel blockers such as nifedipine.15 However,
when the SR has a very high Ca2 accumulation, such as
the RS contraction of rat or GP heart in low Na Tyrode
solution, any decrease in ICa,L seems to be less important
because those contractions are minimally depressed by
nifedipine.19 Consequently, the depression of ICa,L by
desflurane in rat or GP hearts in low Na Tyrode solution
did not reduce CICR, which has been previously ob-
served for sevoflurane.13 The lack of depression is likely
due to the high concentration of SR luminal Ca2 that
seems to prime the RyRs for more complete opening and
release.29 Therefore, even a modest entrance of Ca2
may cause complete RyR activation and Ca2 release
from the SR. In addition, the decreased Na gradient
may foster “reverse” flow and Ca2 entry through the
Na–Ca2 exchanger, and this entering Ca2 may con-
tribute to CICR, compensating for depression of ICa,L.
30
The moderate depression of early tension develop-
ment observed in our results may be mediated by re-
duced SR Ca2 content secondary to a reduction of
inward Ca2 current by desflurane during previous con-
tractions. However, desflurane, like isoflurane,12 enflu-
rane,15 and sevoflurane,13 markedly reduced late force
development in 26 mM K Tyrode solution with 0.1 M
isoproterenol. This depression may be mediated in part
by reduction of the inward Ca2 current and/or by the
reduction of the late SR Ca2 release. Considering the
modest effect on SR Ca2 release in rat and GP myocar-
dium and the reduction of ICa,L by desflurane in the
current results, marked depression of late force develop-
ment is likely to be mediated by reduction of inward
Ca2 current.
Cooling has been shown to increase the open probability
of the RyRs,29,31 and this action likely mediates the Ca2
release that activates the cooling contracture. Desflurane
virtually abolished the force induced by rapid cooling, a
characteristic that also shared with sevoflurane,13 isoflu-
rane,32,33 and enflurane (unpublished results, C. Lynch III,
M.D., Ph.D., Charlottesville, Virginia, 1990). However, in
the current study, there was only a moderate depression of
the 2-Hz contractions by desflurane immediately before
cooling, indicating the presence of significant releasable
pool of Ca2 in the SR sufficient to elicit depolarization-
activated contractile force. The fact that RCC is profoundly
inhibited by fluorinated ether anesthetics suggests that the
functional properties of the SR Ca2 release channel
(RyR2) were altered by such anesthetics while leaving the
more physiologic CICR largely intact.33 The rapid cooling–
induced Ca2 release associated with cold cardioplegia is
associated with decreased recovery of contractile function
versus warm cardioplegia.34 Although this is an interesting
experimental observation, the inhibition of rapid cooling–
induced Ca2 release by desflurane may have clinical sig-
nificance. Anesthetic-induced depression of cooling-in-
duced Ca2 release could result in greater recovery of
contractile function after cold-induced Ca2 release.
The minimal effect of desflurane on rat cardiac RS
contractions as well as on GP myocardium in low Na
Fig. 8. Effect of desflurane on L-type Ca2 current (ICa,L). (A) A
representative example of the effect of desflurane on ICa,L in a
guinea pig ventricular myocytes. The unfilled circles indicate
the peak of an individual current record. The horizontal bar
indicates the period when desflurane was applied. (Inset) An
example of individual currents recorded in the presence of 1.23
mM desflurane. Closed and open circles in the inset indicate
control and 1.23 mM desflurane, respectively. Dotted lines indi-
cate zero current. (B) Depression of ICa,L after application of
0.78 mM and 1.23 mM desflurane. * P < 0.05 versus control.
† P < 0.05 versus 0.78 mM desflurane. Error bars indicate SD.
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are consistent with a modest effect on SR Ca2 uptake and
its depolarization-activated CICR. These findings suggest
that desflurane has a relatively small effect on the amount
of Ca2 stored and released, an observation that is consis-
tent with the results of Gueugniaud et al.10 in isolated rat
ventricular myocardium. Whereas isoflurane12 and sevoflu-
rane13 exhibit effects similar to those of desflurane on SR
function, halothane and possibly enflurane stand in con-
trast with these anesthetic agents by causing a more prom-
inent decrease in initial force development,12,15 probably
by activating the cardiac SR Ca2 release channel and
depleting the SR Ca2 store.35,36
In GP myocardium, we observed that tyramine con-
centration-dependently increased the contractile force
(data not shown). Further, pretreatment with  and 
blockers or reserpine prevented the increase of contrac-
tile force by tyramine, indicating that GP myocardium
has releasable catecholamine pools. In rat myocardium,
Gueugniaud et al.10 demonstrated modest enhancement
of contractile force at various concentrations of desflu-
rane. However, the contractile force of rat myocardium
after - and -adrenoceptor blockade or reserpine ad-
ministration was significantly depressed by desflurane,
suggesting that intramyocardial catecholamine release
induced by desflurane counteracted the anesthetic’s
contractile depression. In contrast, we did not observe
any differences for the effects of desflurane on contrac-
tile force among control, adrenoceptor-blocked, and re-
serpine-treated muscles in GP, indicating a clear species-
dependent difference in desflurane effects on releasable
intramyocardial catecholamines.
To further assess the sympathomimetic effects of des-
flurane in vivo during a rapid increase in desflurane
concentration,37–39 we observed a change in contractil-
ity in two muscles stimulated continuously at 0.5 Hz
after a rapid increase in desflurane concentrations from
3% (vaporizer setting) to 12% (vaporizer setting). In
contrast to the systemic effects observed in vivo, this
rapid increase of desflurane concentration from 3% to
12% decreased the contractile force similarly (data not
shown) to that of a higher desflurane concentration in
modified standard Tyrode solution (fig. 1A). None of our
results suggest that desflurane induces catecholamine
release in the GP ventricular myocardium.
IK is composed of two different current types: a rapidly
activating, inward rectifier current, IKr, and a slowly
activating current, IKs.
40 In the current study, whole cell
voltage clamp experiments indicated that desflurane
suppresses the IK, a property that has been reported for
halothane in GP atrial myocytes,41 and isoflurane42,43
and sevoflurane in GP ventricular myocytes.13 Consider-
ing the higher voltage used in this study, at which IKr is
usually deactivated, the effects of desflurane primarily
represent depression of IKs, which has been found to be
highly sensitive to other inhalational anesthetics such as
isoflurane42,43 and sevoflurane.44 In contrast, IKr seems
to be less or not sensitive to isoflurane43,44 and sevoflu-
rane,44 although it is inhibited by halothane.45 Further
study will be necessary to elucidate the possible effects
of desflurane on IKr.
Although both sevoflurane and isoflurane have been
reported to cause significant depression of inward com-
ponent and enhancement of outward component of
IKI,
46,47 the actual differences from the baseline values
seemed to be modest, suggesting a minimal effect by
these anesthetics on IKI. Modest effects on the inward
and outward components of IKI by sevoflurane have also
been reported in GP ventricular myocytes.13 We also
found that desflurane caused no change in the inward
and outward components of IKI in GP ventricular myo-
cytes. The inward rectifier K current is the primary
current responsible for maintaining a stable cardiac rest-
ing membrane potential near the K equilibrium poten-
tial. Inhibition of IKI can result in diastolic depolariza-
tion, which in turn can cause increased cardiac
excitability48 and lead to dysrhythmias and abnormal
automaticity.49 The lack of change in the resting mem-
brane potential after application of 0.91 mM desflurane
may be attributable to the lack of alteration of IKI.
Our whole cell voltage clamp experiments revealed a
concentration-dependent reduction of peak ICa,L despite
the prolongation of AP duration in normal and slow APs.
Although inhibition of ICa,L can lead to a reduction of AP
duration, the reduction of IKs seems to have a greater
effect, resulting in AP lengthening. Clinically, significant
prolongation of QTc after administration of 1 MAC des-
flurane has also been reported in adults,50 and consider-
ing that prolongation of AP duration induced by clini-
cally relevant concentrations of desflurane in GP
myocytes is most likely due to the suppression of IK, a
similar effect in human myocardium may partially ac-
count for the clinical observation of QT prolongation by
desflurane.
Overall, the actions of desflurane on the various cellu-
lar aspects of Ca2 handling and myocardial contractility
seem to be similar to those previously observed in stud-
ies of isoflurane and sevoflurane. Contractile depression
can be attributed to the depression of Ca2 channel
mediated Ca2 influx through the cardiac membrane.
The rapid initial release of Ca2 from the SR by depolar-
ization seems to be modestly depressed, although alter-
native Ca2 release pathways of the RyR Ca2 release
channels (cold induced) seem to be markedly depressed.
In addition to reduction of ICa,L, a major electrophysi-
ologic effect of desflurane seems to be a depression of
the delayed outward K current, which in turn results in
an increased AP duration.
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